Document is current
Any future updates will be listed below
-
Authors
Basson, Ayelet A.
Weil, Clara
Marx, Steven E. https://orcid.org/0000-0002-2171-1923
Dylla, Douglas E.
Collins, Michelle
Hadadi, Sapir
Chodick, Gabriel
Rahamim-Cohen, Daniella
Lavi, Izana Kaplan
Shibolet, Oren
-
Funding
Funding for this research was provided by:
AbbVie
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 20 December 2024
First Online: 6 February 2025
Declarations
:
: Steven E. Marx, Douglas E. Dylla, Michelle Collins, and Sapir Hadadi are employees of AbbVie and may hold AbbVie stock/options. Gabriel Chodick, Ayelet A. Basson, Clara Weil, Daniella Rahamim Cohen, and Izana Kaplan Lavi are employees of Maccabi Healthcare Services, and Maccabi received an institutional grant from AbbVie. Oren Shibolet is a consultant of AbbVie, Sanofi, Roche, Neopharm, Gilead and MSD, and have received researcher funds and speaker fees from AbbVie, Roche and Gilead.
: The study protocol was approved by the MHS Institutional Review Board (IRB) and was conducted in accordance with the Helsinki Declaration. The IRB issued a waiver of documentation of informed consent for this retrospective study.
